An update on molecular biology and drug resistance mechanisms of multiple myeloma

Highlights • Multiple myeloma (MM), a neoplasm of plasma cells, is the second most common hematological malignancy. • Development of MM involves a series of complex molecular events, including chromosomal abnormalities, oncogene activation and growth factor dysregulation. • MM is a difficult disease...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Critical reviews in oncology/hematology 2015-12, Vol.96 (3), p.413-424
Hauptverfasser:	Mutlu, Pelin, Kiraz, Yağmur, Gündüz, Ufuk, Baran, Yusuf
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents, Alkylating - pharmacology Drug Resistance Hematology, Oncology and Palliative Medicine Humans Male Molecular aspects Multiple myeloma Multiple Myeloma - drug therapy Multiple Myeloma - genetics Multiple Myeloma - pathology Targeted drug delivery
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!